5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
| Image |  |
|---|---|
| Description | scientific article published on 22 August 2017 |
| Author/s |
author: Chiara Borsari Romina Marone Thomas Bohnacker Matthias P Wymann Petra Hillmann Alexander M Sele Paul Hebeisen Marketa J Zvelebil Anna Melone Natasa Cmiljanovic Vladimir Cmiljanovic Denise Rageot Doriano Fabbro Florent Beaufils |
| Publication date | September 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |